This inventor holds 2 USPTO granted patents. Top assignee: Isu Abxis Co., Ltd.. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2012
Title: Mison Koo: Innovator in Inflammation Treatment
Introduction
Mison Koo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of inflammation. With a total of 2 patents, Koo's work focuses on innovative methods to improve immune response.
Latest Patents
Mison Koo's latest patents include groundbreaking research on the treatment of inflammation using a BST2 inhibitor. The first application discloses a method of preventing immune cells from binding to other cells. This method involves contacting the immune cells and the other cells with a composition comprising a Bst2 antagonist. The second patent explores the effect of BST2 on inflammation, detailing a similar approach to prevent immune cell binding through the use of a Bst antagonist.
Career Highlights
Koo is currently associated with Isu Abxis Co., Ltd., a company known for its focus on biopharmaceuticals. His work at the company has positioned him as a key player in the development of new therapeutic strategies.
Collaborations
Mison Koo has collaborated with notable colleagues in his field, including Myung Ki Kim and Jay Chung. Their combined expertise has contributed to the advancement of research in inflammation treatment.
Conclusion
Mison Koo's innovative work in the treatment of inflammation showcases his dedication to improving medical outcomes. His patents reflect a commitment to advancing scientific knowledge and therapeutic options in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile